unknown
Stage
About
Kalaris Therapeutics is a clinical-stage biopharmaceutical company developing novel therapies for prevalent retinal diseases, including neovascular age-related macular degeneration, using engineered biologics to improve anti-VEGF treatment durability and patient outcomes.
Explore Kalaris Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.